Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 27-10-2023
The revenue declined to Rs. 48387.00 millions for the quarter ended September 2023 as compared to Rs. 48803.00 millions during the corresponding quarter last year.Profit saw a slight increase of 6.84%to Rs. 11926.00  millions from Rs. 11163.00 millions.Operating profit for the quarter ended September 2023 decreased to 18522.00 millions as compared to 19208.00 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 48387.00 48803.00 -0.85 102760.00 85109.00 20.74 169625.00 144052.00 17.75
Other Income 2231.00 1180.00 89.07 4567.00 5214.00 -12.41 5913.00 4820.00 22.68
PBIDT 18522.00 19208.00 -3.57 43135.00 29037.00 48.55 48061.00 30761.00 56.24
Interest 58.00 17.00 241.18 103.00 115.00 -10.43 169.00 380.00 -55.53
PBDT 18464.00 19191.00 -3.79 43032.00 28922.00 48.79 47892.00 30381.00 57.64
Depreciation 2458.00 2262.00 8.66 4830.00 4477.00 7.88 9232.00 8143.00 13.37
PBT 16006.00 16929.00 -5.45 38202.00 24445.00 56.28 38660.00 22238.00 73.85
TAX 4080.00 5766.00 -29.24 9882.00 8287.00 19.25 12532.00 6006.00 108.66
Deferred Tax 120.00 2790.00 -95.70 535.00 3953.00 -86.47 3891.00 2080.00 87.07
PAT 11926.00 11163.00 6.84 28320.00 16158.00 75.27 26128.00 16232.00 60.97
Equity 834.00 832.00 0.24 834.00 832.00 0.24 833.00 832.00 0.12
PBIDTM(%) 38.28 39.36 -2.74 41.98 34.12 23.04 28.33 21.35 32.69